HUM

NYSE Humana Inc.
Oct 15, 2026 · 12:36 PM ET DELAYED Market Open

$434.76 ↑ +7.36 (+1.72%) Trading Up from the previous close of $427.40, $1.98 below the day’s high of $436.74

YTD change
+69.74%
vs 20-day SMA
+9.99%
vs 200-day SMA
+45.20%

Price ranges

Previous day
$421.61 $432.15
open $421.61 close $427.40
+$5.79 (+1.37%)
Today
$429.44 $436.74
open $430.00 now $434.76
+$4.76 (+1.11%)
Past week
$375.86 $456.50
from $396.51 now $434.76
+$38.25 (+9.65%)
Past month
$369.13 $456.50
from $384.72 now $434.76
+$50.04 (+13.01%)
This year
$163.11 $456.50
from $256.13 now $434.76
+$178.63 (+69.74%)

Price & Performance

+229.03 (+115.46%) / 6M

$179.56$270.48$361.39$452.31Apr 15Jul 16Oct 14

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Very Good
  • The stock is 23.9% away from all-time highs of $571.30
  • HUM is up 70% since the beginning of the year
  • HUM is up 66% over the past 12 months
  • HUM is up 13% over the past 1 month
  • 2% of all HUM investors are betting against HUM
  • Number of investors short HUM has gone down 10% versus last month

HUM reads very good: price sits above both the 20- and 200-day averages, short interest is falling month over month, the 12-month move is +63.0%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable Yes
EPS $7.61
Earnings momentum +860.4% Quarterly EPS growth
Quarterly change +860.4%

Valuation

P/E ratio 39.70
Enterprise value $59.2B
Beta 1.42

Balance sheet & scale

Income$1.3M
Revenue$145.7B
CashN/A
Debt$14.2M
Income / Debt 0.09×

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNYSE
Sector Health Care and Social Assistance
Sub Sector Ambulatory Health Care Services
Market cap $52.2B

Humana Inc. engages in the provision of health insurance services. It operates through the Insurance and CenterWell segments. The Insurance segment consists of Medicare benefits, marketed to individuals or directly via group Medicare accounts, as well as contract with CMS to administer the Limited Income Newly Eligible Transition, or LI-NET, prescription drug plan program and contracts with various states to provide Medicaid, dual eligible demonstration, and Long-Term Support Services benefits, which refer to as state-based contracts. The CenterWell segment represents payor-agnostic healthcare services offerings, including pharmacy dispensing services, provider services, and home services. The company was founded by David A. Jones, Sr., and Wendell Cherry on August 18, 1961 and is headquartered in Louisville, KY.

Competitor comparison

TickerCompany PriceChange
AGL agilon health inc $87.40 +1.75%
STLN Starling Oncology Inc. $6.51 -2.84%
AUNA Auna S.A. Class A $5.25 -1.50%
AIRS Airsculpt Technologies, Inc. $1.42 -12.35%
QDMI QDM International Inc. $10.00 +0.00%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.